MainFeedbackSite mapRussian
 

Business Segments

 

News

27.08.2015
Protek Group announces financial results for 1HY-2015
Protek Group (PRTK:RTS, MICEX), one of the major pharmaceutical companies in Russia operating in all the segments of the pharmaceutical market (production, distribution, and retail sales), announces its audited IFRS results for 1HY-2015.
23.06.2015
OAO PROTEK held General Shareholders Meeting
On 23 June 2015, OAO PROTEK, one of the largest Russian pharmaceutical holding companies, held its annual meeting.
21.04.2015
Protek Group announces FY-2014 financial results
Protek Group (PRTK:RTS, MICEX), one of the major pharmaceutical companies in Russia operating in all the segments of the pharmaceutical market (production, distribution, and retail sales), has announced its audited IFRS results for FY-2014.
11.02.2015
Protek Group announces preliminary operational results for Q4-2014 and 12M-2014
Protek Group (PRTK: RTS, MICEX), a major Russian pharmaceutical company announces its preliminary operational results for Q4-2014 and 12M-2014 according to the management accounts (unaudited)*.
02.12.2014
«Rigla» - the leader of pharmacy chain rating for 9 months 2014 – rating by IMS
Pharmacy chain Rigla keeps its leadership in a “Complex rating of national pharmacy chains” – rated by IMS, for 9 months 2014. According to the rating, the Rigla’s market share accounted for 3,05%.
29.10.2014
Protek Group announces preliminary operational results for Q3-2014 and 9M-2014
Protek Group (PRTK: RTS, MICEX), a major Russian pharmaceutical company announces its preliminary operational results for Q3-2014 and 9M-2014 according to the management accounts (unaudited)*.
16.09.2014
OAO Protek announces dividend payment based on unaudited 1HY-2014 RAS financial results
OAO Protek (PRTK: RTS, MICEX), a major Russian pharmaceutical company, announces that its General Shareholders Meeting resolved to distribute and pay dividends out of the Company's net profit based on 1HY-2014 RAS financial results.
27.08.2014
Protek Group announces financial results for 1HY-2014
Protek Group (PRTK:RTS, MICEX), one of the major pharmaceutical companies in Russia operating in all the segments of the pharmaceutical market (production, distribution, and retail sales), announces its audited IFRS results for 1HY-2014.
18.07.2014
Pharmaceutical plant “Sotex” opened production site for erythropoietin substance

Pharmaceutical plant “Sotex”, which is part of “PROTEK” group of companies, opened a site for production of genetically engineered erythropoietin substance - active ingredient of drug Eralfon® - as a part of the second stage of developing the plant’s capacity.

24.06.2014
OAO PROTEK held General Shareholders Meeting
On 24 June 24, OAO PROTEK, one of the largest Russian pharmaceutical holding companies, held its annual meeting.
Subscribe
1 2 3 4 5 ... 21



Sotex «PharmFirm» Protek-SVM Protein contour CV Protek Spargo Technologies TRANSSERVICE Customs PROMOPHARM Rigla